C84.00

Clinical Causes: The exact cause of mycosis fungoides is unknown, but it involves abnormalities in the immune system that lead to the uncontrolled growth of T-lymphocytes. Genetic factors may play a role, as certain gene mutations have been associated with the disease. Environmental influences such as exposure to certain chemicals or radiation have been considered, although definitive links are not well established. Possible links to prior infections or immune system triggers are being studied, but no definitive cause has been identified.

Key Symptoms: Persistent skin patches that may appear red, scaly, and slightly raised Papules, which are small, elevated, and often itchy skin bumps Plaques that are thickened, rough patches on the skin, sometimes with a leathery appearance In advanced stages, tumors or sores may develop on the skin Itching or a burning sensation on affected skin areas Localized or generalized skin involvement, often symmetrically distributed

Diagnosis Path: Diagnosis involves a combination of clinical evaluation, skin biopsies, and laboratory tests. Physicians typically perform a skin examination for characteristic patches, plaques, or tumors. A skin biopsy, where a small sample of affected skin is examined microscopically, is essential to identify the abnormal T-cell proliferation characteristic of mycosis fungoides. Additional tests may include blood tests, imaging studies, and immunophenotyping to assess the extent of the disease and rule out other conditions.

Treatment Protocols: Topical therapies such as corticosteroids, retinoids, or chemotherapy creams to reduce skin lesions Phototherapy, especially ultraviolet light therapy, to target affected skin areas Radiation therapy for localized tumors or stubborn plaques Systemic treatments, including chemotherapy, immunotherapy, or targeted agents for advanced stages Biologic drugs that modulate the immune system's response Supportive skin care to manage itching and prevent infections